Clinical Trial Update: A Proof-of-Concept Study Assessing NEO6860 in Osteoarthritis Pain [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept study evaluating NEO6860 for knee osteoarthritis pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• NEO6860

Snippet

Sponsor: Neomed Institute | Conditions: Pain, Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED